Paramount has sweetened its offer for Warner Bros. Discovery, adding a so-called "ticking fee" to signal regulatory confidence among other new elements.
The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.
The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing misleading claims about the pill.
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.